WO2013137797A1 - Apparatus and method for monitoring of mechanical ventilation - Google Patents

Apparatus and method for monitoring of mechanical ventilation Download PDF

Info

Publication number
WO2013137797A1
WO2013137797A1 PCT/SE2013/000035 SE2013000035W WO2013137797A1 WO 2013137797 A1 WO2013137797 A1 WO 2013137797A1 SE 2013000035 W SE2013000035 W SE 2013000035W WO 2013137797 A1 WO2013137797 A1 WO 2013137797A1
Authority
WO
WIPO (PCT)
Prior art keywords
resetting
ventilator
elimination
monitoring
change
Prior art date
Application number
PCT/SE2013/000035
Other languages
French (fr)
Inventor
Björn Jonson
Original Assignee
Innotek Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innotek Ab filed Critical Innotek Ab
Publication of WO2013137797A1 publication Critical patent/WO2013137797A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/083Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
    • A61B5/0836Measuring rate of CO2 production
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B16/00Devices specially adapted for vivisection or autopsy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • A61M16/026Control means therefor including calculation means, e.g. using a processor specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/20Valves specially adapted to medical respiratory devices
    • A61M16/201Controlled valves
    • A61M16/202Controlled valves electrically actuated
    • A61M16/203Proportional
    • A61M16/204Proportional used for inhalation control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/20Valves specially adapted to medical respiratory devices
    • A61M16/201Controlled valves
    • A61M16/202Controlled valves electrically actuated
    • A61M16/203Proportional
    • A61M16/205Proportional used for exhalation control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/04Tracheal tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/12Preparation of respiratory gases or vapours by mixing different gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/14Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A61M16/16Devices to humidify the respiration air
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A61M2016/0036Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the breathing tube and used in both inspiratory and expiratory phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A61M2016/0039Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the inspiratory circuit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A61M2016/0042Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the expiratory circuit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/40Respiratory characteristics
    • A61M2230/43Composition of exhalation
    • A61M2230/432Composition of exhalation partial CO2 pressure (P-CO2)

Definitions

  • the present invention relates to an apparatus used at mechanical ventilation of man or animal, hereafter referred to as "the patient”, for follow up of physiological effects of a change of ventilator setting, allowing the operator to nearly immediately evaluate effects of ventilator resetting according to the preamble of claim 1. Thereby the operator timely receives information allowing judgement of physiological effects of the new setting with regards to therapeutic and physiological goals.
  • the properties of the respiratory system comprising airways, lung parenchyma, alveoli, pulmonary blood vessels, heart and thoracic cage are complex, particularly so in disease.
  • the operator of a ventilator usually a physician or a respiratory therapist, frequently changes the setting of a ventilator.
  • the purpose behind resetting is to reach desired goals of mechanical ventilation. Due to the complexity of physiology, it is in general not possible to foresee which effects a certain resetting will have on respiratory mechanics, gas exchange and circulation. Therefore, the effects need to be evaluated by measuring the physiological status before and after resetting.
  • a particularly important parameter is arterial partial pressure of carbon dioxide, P a C0 2 , that reflects alveolar ventilation and influences arterial pH.
  • the body contains large amounts of exchangeable carbon dioxide, C0 2 .
  • C0 2 exchangeable carbon dioxide
  • C0 2 exchange is only one phenomenon that needs to be monitored during mechanical ventilation, particularly in conjunction with ventilator resetting.
  • High tidal volumes and high airway pressures are injurious to the lung and must be controlled to avoid ventilation induced lung injury, VI LI.
  • VI LI ventilation induced lung injury
  • RECOREX repetitive lung collapse and re- expansion of lung units, RECOREX, is a particularly injurious process that must be avoided.
  • parameters refer to oxygen and carbon dioxide exchange, volumes and pressures associated with the ventilation process.
  • High intrapulmonary pressures may perturb circulation. Therefore also parameters relating to circulation need to be monitored.
  • a method that may alleviate problems to foresee effects of resetting a ventilator is computer simulation of potential effects of ventilator resetting. Such simulation is based upon a physiological profile of the respiratory system and a mathematical description of the function of a ventilator at different settings. Such a method is described in U.S. patent 6,578,575 B1. The accuracy of the prediction based upon computer simulation is limited by the non- exactness of the physiological profile and by such changes in physiology, which may be the results of the resetting. Accordingly, there is always a need to follow up effects of ventilator resetting.
  • the objective of the present invention is to make possible evaluation of physiological effects following ventilator resetting within a limited number of breaths after resetting, preferably while the operator performing the resetting is present at bedside.
  • the physiological effects in question include effects on airway pressure, for example mean airway pressure, peak airway pressure, postinspiratory plateau pressure, and positive end-expiratory pressure, PEEP.
  • Other physiological effects are end tidal concentration of C0 2 , volume of C0 2 eliminated by ventilation per minute, V M
  • Physiological effects are measured with sensors providing signals, which are analyzed using a computer.
  • the sensors and the computer may be integrated with the ventilator into one single apparatus.
  • An alternative is that the sensors are the same as those of the ventilator and that a separate computer receives the signals from those sensors and performs the analysis.
  • Signals representing circulation, such as arterial pressure are commonly recorded by special monitoring equipment, the information from which may be entered to the system according to a preferred embodiment of the invention.
  • Another alternative according to an embodiment of the invention is that both sensors and the computer are separate from the ventilator. This form of embodiment can be used in combination with different kinds of ventilators. Recording and analysis of signals are started before resetting is performed and continue through the resetting and during a period after resetting.
  • the computer reports how selected physiological parameters changed allowing the operator to judge if the changes are in line with expectations and accord with the objectives behind resetting.
  • the signals are analyzed with respect to noise and to trends caused by physiological phenomena related to non-instant establishment of a steady state. Thereby effects on for example V MIN C0 2 and PaC0 2 caused by resetting are exposed.
  • Figure 1 illustrates an apparatus that accords with a preferred embodiment of the invention.
  • the apparatus is only schematically depicted, since configuration options are virtually unlimited with modern technology.
  • a pneumatic inspiratory system of the ventilator comprises inlets for gases like air and oxygen 2, a blender for the gases 3 and a flow controller in the inspiratory line 4.
  • the blender 3 and the controller 4 are integrated into a single unit.
  • the inspiratory line is equipped with a flow meter 5. Outside the ventilator or integrated into the ventilator the inspiratory line is often equipped with a humidifier 6 and continues in the form of a flexible inspiratory tube 7 that leads to the Y-piece 8.
  • the ventilator is connected to the patient 10 with a tracheal tube 9 but can be connected by other means.
  • Expiration occurs through a pneumatic expiratory system of the ventilator starting at the Y-piece 8 and further through a flexible expiratory tube 11, an expiratory valve 12 and an expiratory flow meter 13.
  • the order of 12 and 13 may be the opposite.
  • a C0 2 analyzer 14 measures fraction of C0 2 at the Y-piece.
  • a pressure transducer 15 measures airway pressure. It can alternatively be connected to the expiratory line 11 or be duplicated in both inspiratory line and in expiratory line.
  • the function of the ventilator is controlled by an electronic control unit 17 that may be an analogue or digital device.
  • the control unit comprises at least one computer that records and analyzes the signals from flow, pressure and C0 2 transducers 5, 13, 15 and 14. This computer can also receive signals from systems for monitoring of circulation such as arterial pressure.
  • the control unit is able to communicate with the user through a keyboard, by touch controls or by other means. Communication is also possible from distance, e.g. from a central system in a critical care unit. All the stipulated parts can be integrated into a single apparatus or functionally distributed among different apparatuses. The latter option could mean that e.g. the function serving to control the pneumatic systems is located within the ventilator, whereas e.g. calculation and monitoring functions are physically located in another apparatus such as an external computer.
  • the control unit receives analogue or digital signals representing flow rate, pressure and C0 2 and sends signals to the inspiratory and expiratory valves 4 and 12 through means for electronic communication 16.
  • the control unit may apart from components within the ventilator itself comprise components and systems outside the ventilator.
  • the technique of today offers virtually limitless possibilities to embody the invention with respect to technical solutions of electronic components and their communication with each other by wired or wireless means.
  • Monitoring of the ventilation process may be achieved by a system incorporated in the ventilator or by a system outside the ventilator but communicating with the control unit inside the ventilator.
  • the control unit 17 is in a preferred embodiment of the invention equipped with a visual screen for monitoring of flow and pressure signals and for display of other information.
  • FIG. 2 illustrates an alternative preferred embodiment of the invention in which the numbers 1-17 indicate the same structures as in Figure 1.
  • the system used for monitoring according to the present invention is embodied with an apparatus that is separate from the ventilator 1.
  • the monitoring apparatus comprises a computer 20 and transducers for C0 2 14 flow rate 18 and airway pressure 19, which through wired or wireless means of communication 21 send signals to the computer 20.
  • the invention can be applied to any type of ventilator.
  • the computer 20 may receive signals for one or more of the parameters flow rate, airway pressure and C0 2 from transducers integrated in the ventilator thus avoiding duplication of transducer equipment.
  • the computer 20 may also have access to other information from the ventilator 1 such as ventilator setting, respiratory rate and information about timing of partitions of the respiratory cycle through a digital or analogue, wired or wireless communication link.
  • the computer 20 may receive information from other sources such as those used for monitoring of circulation like arterial pressure.
  • Figure 3 illustrates a monitoring screen in conjunction with ventilator resetting in a patient with ARDS that was performed at the time 2 minutes.
  • the upper panel A shows Respiratory rate, tidal volume, V T , and Positive End Expiratory Pressure, PEEP.
  • V T is obtained by integration of the flow signal over each breath.
  • PEEP is measured by the transducer 15 or 19.
  • Panel B shows post inspiratory plateau pressure, P PLA T, and the difference between P PLAT and PEEP denoted delta-P.
  • delta-P should represent the true difference of the elastic recoil pressure of the respiratory system after and before inspiration. To measure these values exactly, the patient needs to be passive and airway flow rate zero at these moments. Zero flow rate can be achieved with some modern ventilators by closing the valves 4 and 12.
  • P PLAT can be determined at minimal inspiratory flow rate towards the end of inspiration.
  • PEEP can be determined at minimal expiratory flow rate towards the end of expiration.
  • These PEEP values can be corrected for flow and resistance dependent pressure gradients in the airways according to principles described by Jonson et al. (Bull. Physiopath. Resp. 1975, v 11 , pp 729-743)
  • Panel C illustrates the volume of C0 2 eliminated per minute through ventilation, V M
  • V M INC0 2 is calculated from the volume of C0 2 eliminated during each breath divided by the duration of the breath.
  • N C0 2 is derived from integration of the product between flow rate and fraction of C0 2 measured at airway opening.
  • Panel D is a recording of peripheral saturation of oxygen, S P 0 2 , measured by conventional means and Panel E shows end tidal C0 2 , E T C0 2 .
  • FIG. 4 Panel A illustrates how different kind of noise can affect the signals, e.g. the one representing V M INC0 2 .
  • Such noise will negatively affect the precision in determination of the change in V M INC0 2 that occurs after ventilator resetting, in this example at 2 minutes.
  • a slow drift is common in V UIN C0 2 that may reflect changing metabolic rate due to variation in body temperature or varying inflammatory activity in the body as well as other reasons for changing homeostasis.
  • a second type of noise is caused by breath by breath variation in volume of C0 2 eliminated. This variation has several causes such as measurement errors, breath by breath variation in tidal volume and varying pulmonary perfusion at heart arrhythmia.
  • V M breath by breath noise in V M)N C0 2
  • V M breath by breath noise in V M)N C0 2
  • V M breath by breath noise in V M)N C0 2
  • V M breath by breath noise in V M)N C0 2
  • N C0 2 the value of V M INC0 2 before resetting
  • N C0 2 will immediately increase or decrease to a new value V M
  • the change will be indirectly proportional to the change in effective alveolar ventilation.
  • N C0 2 will slowly return towards the value that represents current metabolic C0 2 production following an exponential course.
  • N C0 2 data after resetting are used to analyze this course by statistical means as further described below and in Figure 4 shown by a heavy line representing decline towards baseline.
  • N C0 2 is determined from the difference between the V M i N C0 2 reset and V M i N C0 2 baseline as illustrated by interrupted vertical line in Figure 4.
  • Figure 5 shows a numerical display of the same parameters as depicted in figure 3 based on data during 2 minutes before ventilator resetting and 15 s to 2 minutes after resetting.
  • a change is according to a preferred embodiment of the invention accompanied by information about its statistical significance. In this example significant changes (p ⁇ 0.05) are highlighted in bold characters. SE is standard error of the estimation. Description of preferred embodiments
  • the system is based upon sensors for airway flow rate, airway pressure and C0 2 as illustrated in Figure 1 and 2.
  • Flow rate and airway pressure may be measured within the ventilator 5, 13 and 15 in Figure 1 or at the airway opening of the patient 18, 19 in Figure 2.
  • C0 2 is measured at the airway opening 14.
  • C0 2 is measured somewhere along the expiratory pneumatic system. Then, the small volume of C0 2 re-inspired at the start of inspiration from the Y-piece 8 and the inspiratory and expiratory lines 7 and 11 will not be measured. This limitation may be balanced by technical advantages of this alternative embodiment.
  • signals for flow rate, airway pressure and C0 2 should have an adequate frequency response and be adequately in synchrony with each other so that events during breaths representing each signal or combinations of signals can be accurately recorded and monitored.
  • Optional transducers for S P 0 2 , arterial pressure and other signals are foreseen to be incorporated in alternative preferred embodiments of the invention.
  • a computer that may be integrated into the ventilator 17 or be a separate computer 20 samples the signals for C0 2 , airway pressure and flow at an adequate rate. These signals, together with data calculated from the signals and other information may be displayed and stored by the computer in accordance with conventional monitoring systems. Accordingly, volumes are calculated by integration of flow rate over time. Respiratory rate in breaths per minute may be derived from signals controlling the valves of the ventilator 4, 12 or from analysis of pressure and flow signals by the computer 17 or 20.
  • the objective of the present invention is to monitor parameters providing the most essential information with respect to goal achievement of mechanical ventilation and risks associated with mechanical ventilation and particularly how ventilator resetting affects these parameters.
  • Figure 3 illustrates an example of combinations of such parameters. The combination of parameters may be varied for example with the nature of the disease of the patient and availability of optional transducer signals. The traced parameters are accompanied by numeric information. An example is given in Figure 5.
  • Panel A shows respiratory rate, PEEP and V T , all of which at controlled ventilation are parameters directly related to ventilator setting.
  • Panel B shows the end expiratory plateau pressure, PPLAT, that is the pressure at zero of very low flow rate at the end of an inspiration.
  • P PL A T is the commonly used parameter that indicates the degree of lung distension that when too high will cause lung damage related to hyperdistension.
  • delta-P is the difference between P PLA T and PEEP and is a recommended parameter to estimate risks for VI LI.
  • Panel C describes the elimination of C0 2 eliminated per minute, V M
  • Panels D and E show tracings of peripheral oxygen saturation and end tidal C0 2 concentration.
  • the primary objective of ventilation is exchange of 0 2 and C0 2 so that arterial blood will acquire adequate properties with respect to these gases.
  • S P 0 2 the arterial partial pressure of C0 2 , PaC0 2
  • PaC0 2 cannot be accurately estimated without analysis of arterial blood samples. Then, apart from blood sampling and costs, a further problem is that the change in PaC0 2 occurs slowly after a change of alveolar ventilation caused by ventilator resetting. This is due to large C0 2 stores in body fluids.
  • PaC0 2 An alternative to PaC0 2 is to measure end tidal partial pressure of C0 2 , E T C0 2 .
  • E T C0 2 is easily obtained from the transducer 14.
  • E T C0 2 often differs greatly from PaC0 2 .
  • a change of E T C0 2 occurs after a similar delay as PaC0 2 and is influenced by several physiological effects which change with time and with ventilator setting.
  • APaC0 2 can according to the invention be estimated within short after resetting as explained below.
  • N C0 2 averaged over so long time that body stores of C0 2 may be regarded as constant represents the rate of C0 2 production that is proportional to aerobic metabolic rate.
  • N C0 2 observed after ventilator resetting over such a short time that metabolic rate and body stores of C0 2 can be regarded as constant reflects a change of efficient alveolar ventilation, which equals total ventilation minus physiological dead space ventilation. Therefore, the determination of the change in V M INC0 2 occurring immediately after resetting, AV M
  • FIG. 4 illustrates how the influence of noise on measured AV M INC0 2 according to a preferred embodiment of the invention is reduced to a level that under most circumstances is adequately low.
  • N C0 2 baseline is calculated from statistical analysis of values during a period preceding ventilator resetting. This analysis not only minimizes breath by breath variation but also allows determination of slow drift. Values after ventilator resetting are corrected for the slow drift characterized before resetting.
  • V MIN C0 2 reset is according to preferred embodiments of the invention obtained by statistical analysis of data after resetting. This analysis serves to characterize the slow asymptotic return towards steady state corresponding to the metabolic production of C0 2 . According to a preferred embodiment of the invention an exponential return is anticipated, but similar results may be obtained using alternative mathematical expressions.
  • Ventilator resetting does not always occur at a specific moment, e.g. when more than one parameter is changed as in the example behind Figure 3. Furthermore, a feature of some ventilators is that ventilator setting is not immediately executed at the moment of resetting but implemented over some breaths. Accordingly, the first breaths following the initiation of resetting must pass before data defining the course of V M
  • the accuracy of AV M)N C0 2 is reduced by noise of the V M INC0 2 signal.
  • the level of noise is according to a preferred embodiment of the invention statistically analyzed. Thereby the influence of noise on the determination of AV M
  • the fraction AV M iNC0 2 reset/V M iNC0 2 baseline shows to what extent alveolar ventilation changed in conjunction with ventilator resetting and can be expressed in percent, AV M
  • data sets for V M)N C0 2 2 minutes before and 15 s to 2 minutes after resetting were analyzed. Two minutes may be a suitable default value for those periods.
  • V M INC0 2 In the presence of heavy noise in the tracing of V M INC0 2 longer periods may be automatically or manually instituted in order to increase the accuracy of AV M I C0 2 determination. At controlled ventilation respiratory rate is usually constant. Then, values of eliminated volumes of C0 2 per breath may be used instead of values for V M INC0 2 for calculation of the change of C0 2 elimination in conjunction with ventilator resetting.
  • PaC0 2 is proportional to metabolic C0 2 production and indirectly proportional to efficient alveolar ventilation.
  • the change of PaC0 2 that will follow resetting after equilibration of body fluid stores of C0 2 is according to a preferred embodiment of the invention estimated from AV M INC0 2 %.
  • AV M INC0 2 % was +7% with an estimated range between +6 and +8%.
  • the values for range were estimated using ordinary statistical methods as the 95% confidence interval. This interval serves as default according to a preferred embodiment of the invention. Accordingly, the expected relative change of PaC0 2 after equilibration was -7%, range -8 to -6%.
  • An alternative to range is to report standard error of the estimated change of PaC0 2 as illustrated in Figure 5.
  • the estimated PaCC1 ⁇ 2 value after resetting will according to a preferred embodiment of the invention be presented to the operator. If the computer 17 or 20 also has access to present pH value and the acid base status for example expressed as Base excess, the computer can also calculate the expected change in pH by using standard well known equations. The following serves as an example:
  • each data point represent a single breath. This is at controlled ventilation a preferred embodiment of the invention. At very irregular breathing V M INC0 2 and other parameters like tidal volume may vary much between breaths.
  • An alternative embodiment of the invention is to measure parameters over longer periods of time rather than per breath. Determination of volumes of e.g. C0 2 on the basis of gas flow rate and fraction of C0 2 are affected by conditions at which flow rate and C0 2 are measured. Conditions may vary before and after ventilator resetting, particularly with respect to pressure. According to a preferred embodiment of the invention, corrections are made to standardized conditions, for example BTPS (body temperature, atmospheric pressure and saturated with water vapour) or STPD (standard temperature and pressure, saturated).
  • BTPS body temperature, atmospheric pressure and saturated with water vapour
  • STPD standard temperature and pressure, saturated
  • N C0 2 before and after resetting is made by statistical analysis of data sets for each signal sampled before and after resetting. For most parameters, a steady state is to be expected already within a few breaths after resetting. Accordingly, the level of a particular physiological parameter after resetting is determined on the basis of data during a period that according to default setting starts 5 breaths or 15 s after the last resetting and ends 2 minutes later, as for the analysis of V M
  • End tidal C0 2 has its own particular behaviour after ventilator resetting. As a first approximation it will fall at a rate and to a degree similar to that of PaC0 2 , following an exponential course. However, E T C0 2 is affected by more physiological factors than PaC0 2 . When for example the respiratory rate is increased and tidal volume decreased, the difference between E T C0 2 and PaC0 2 will under most circumstances increase. E T C0 2 is also affected by the cardiac output and intrapulmonary shunt fraction, which are often affected after ventilator resetting.
  • E T C0 2 As variation of E T C0 2 is complexly affected by both slow and fast phenomena it is in general not useful to predict its upcoming steady state value after ventilator resetting but rather to trace its variation with time as in Figure 3. In spite of the complexity of E T C0 2 changes it is of value to display this parameter. E T C0 2 may suddenly fall at an important suppression of pulmonary perfusion that may happen after unsuitable ventilator resetting. At such an event, also V M INC0 2 falls suddenly. A sudden fall of both E T C0 2 and V M
  • FIG. 5 shows an example based upon the data in Figure 3.
  • the parameters displayed graphically and numerically can be selected in a set up procedure of systems like those in Figure 1 and 2.
  • This option includes parameters not shown in Figure 3.
  • Examples are mean airway pressure and total PEEP.
  • Total PEEP is the pressure in alveoli at the end of expiration that can be measured during a post-expiratory pause or estimated according to principles described by Jonson et al. (Bull. Physiopath. Resp. 1975, v 11 , pp 729-743).
  • signals from haemodynamic monitoring systems and meters for S P 0 2 are transmitted to the computer 17, 20. Such parameters are monitored and analyzed in analogy with parameters from inherent transducers.

Abstract

The invention relates to an apparatus for monitoring of physiological parameters at mechanical ventilation. The objective is to identify beneficial and injurious effects of ventilator resetting within few breaths while the operator remains at bedside. Monitored parameters include e.g. tidal volume, airway pressures, end tidal CO2, haemodynamics and volume of CO2 eliminated per minute, VMINCO2. Data sets of each signal before and after resetting are statistically analyzed to reduce noise and to allow accurate presentation of changes in conjunction with resetting. The quotient between VMINCO2 after and before resetting is used to illustrate the effect on alveolar ventilation and thereby effects on arterial partial pressure of CO2. The course of VMINCO2 after resetting is analyzed to get an accurate value of VMINCO2 after resetting. The invention can be used at different modes of ventilation because of noise reducing strategies, which are of particular importance at supported and irregular ventilation.

Description

APPARATUS AND METHOD FOR MONITORING OF MECHANICAL VENTILATION
Description of the invention
Field of the invention
The present invention relates to an apparatus used at mechanical ventilation of man or animal, hereafter referred to as "the patient", for follow up of physiological effects of a change of ventilator setting, allowing the operator to nearly immediately evaluate effects of ventilator resetting according to the preamble of claim 1. Thereby the operator timely receives information allowing judgement of physiological effects of the new setting with regards to therapeutic and physiological goals.
Description of the Prior Art
The properties of the respiratory system comprising airways, lung parenchyma, alveoli, pulmonary blood vessels, heart and thoracic cage are complex, particularly so in disease. The operator of a ventilator, usually a physician or a respiratory therapist, frequently changes the setting of a ventilator. The purpose behind resetting is to reach desired goals of mechanical ventilation. Due to the complexity of physiology, it is in general not possible to foresee which effects a certain resetting will have on respiratory mechanics, gas exchange and circulation. Therefore, the effects need to be evaluated by measuring the physiological status before and after resetting. A particularly important parameter is arterial partial pressure of carbon dioxide, PaC02, that reflects alveolar ventilation and influences arterial pH. The body contains large amounts of exchangeable carbon dioxide, C02. This implies that a change of alveolar ventilation leads to a slow change in PaC02. It takes more than 20 minutes to reach a new steady state with regards to PaC02 and arterial pH after resetting. Accordingly, an arterial sample does not properly indicate the effect on PaC02 until long after resetting. During that interval other physiological events may obscure the effect of resetting. Therefore, there is a need for faster feedback to the operator than that obtained with conventional monitoring methods.
C02 exchange is only one phenomenon that needs to be monitored during mechanical ventilation, particularly in conjunction with ventilator resetting. High tidal volumes and high airway pressures are injurious to the lung and must be controlled to avoid ventilation induced lung injury, VI LI. In the acute respiratory distress syndrome repetitive lung collapse and re- expansion of lung units, RECOREX, is a particularly injurious process that must be avoided. To get an overview of the ventilation process with respect to goals which should be reached and risks for VILI a number of parameters need to be monitored. These parameters refer to oxygen and carbon dioxide exchange, volumes and pressures associated with the ventilation process. High intrapulmonary pressures may perturb circulation. Therefore also parameters relating to circulation need to be monitored. A large variety of physiological parameters are indeed monitored with several systems on the market, but not in a comprehensive way, easy to survey with relation to goals and dangers of the ventilation process. Delays of the physiological response to resetting and noise in the recorded signals are factors which make it difficult to survey physiological effects of resetting in prior art systems.
A method that may alleviate problems to foresee effects of resetting a ventilator is computer simulation of potential effects of ventilator resetting. Such simulation is based upon a physiological profile of the respiratory system and a mathematical description of the function of a ventilator at different settings. Such a method is described in U.S. patent 6,578,575 B1. The accuracy of the prediction based upon computer simulation is limited by the non- exactness of the physiological profile and by such changes in physiology, which may be the results of the resetting. Accordingly, there is always a need to follow up effects of ventilator resetting.
The invention
The objective of the present invention is to make possible evaluation of physiological effects following ventilator resetting within a limited number of breaths after resetting, preferably while the operator performing the resetting is present at bedside. The physiological effects in question include effects on airway pressure, for example mean airway pressure, peak airway pressure, postinspiratory plateau pressure, and positive end-expiratory pressure, PEEP. Other physiological effects are end tidal concentration of C02, volume of C02 eliminated by ventilation per minute, VM|NC02, and change of PaC02 and pH in blood imposed by resetting at a new steady state. Oxygen saturation in blood studied in the periphery, SP02, is an important parameter. Physiological effects are measured with sensors providing signals, which are analyzed using a computer. The sensors and the computer may be integrated with the ventilator into one single apparatus. An alternative is that the sensors are the same as those of the ventilator and that a separate computer receives the signals from those sensors and performs the analysis. Signals representing circulation, such as arterial pressure, are commonly recorded by special monitoring equipment, the information from which may be entered to the system according to a preferred embodiment of the invention. Another alternative according to an embodiment of the invention is that both sensors and the computer are separate from the ventilator. This form of embodiment can be used in combination with different kinds of ventilators. Recording and analysis of signals are started before resetting is performed and continue through the resetting and during a period after resetting. Within a number of breaths, or within few minutes after resetting, the computer reports how selected physiological parameters changed allowing the operator to judge if the changes are in line with expectations and accord with the objectives behind resetting. According to a preferred embodiment of the invention the signals are analyzed with respect to noise and to trends caused by physiological phenomena related to non-instant establishment of a steady state. Thereby effects on for example VMINC02 and PaC02 caused by resetting are exposed.
Description of the drawings
Figure 1
Figure 1 illustrates an apparatus that accords with a preferred embodiment of the invention. The apparatus is only schematically depicted, since configuration options are virtually unlimited with modern technology.
A pneumatic inspiratory system of the ventilator comprises inlets for gases like air and oxygen 2, a blender for the gases 3 and a flow controller in the inspiratory line 4. In an alternative embodiment of the invention the blender 3 and the controller 4 are integrated into a single unit. The inspiratory line is equipped with a flow meter 5. Outside the ventilator or integrated into the ventilator the inspiratory line is often equipped with a humidifier 6 and continues in the form of a flexible inspiratory tube 7 that leads to the Y-piece 8. The ventilator is connected to the patient 10 with a tracheal tube 9 but can be connected by other means. Expiration occurs through a pneumatic expiratory system of the ventilator starting at the Y-piece 8 and further through a flexible expiratory tube 11, an expiratory valve 12 and an expiratory flow meter 13. The order of 12 and 13 may be the opposite. A C02 analyzer 14 measures fraction of C02 at the Y-piece. A pressure transducer 15 measures airway pressure. It can alternatively be connected to the expiratory line 11 or be duplicated in both inspiratory line and in expiratory line.
The function of the ventilator is controlled by an electronic control unit 17 that may be an analogue or digital device. In a preferred embodiment of the invention the control unit comprises at least one computer that records and analyzes the signals from flow, pressure and C02 transducers 5, 13, 15 and 14. This computer can also receive signals from systems for monitoring of circulation such as arterial pressure. The control unit is able to communicate with the user through a keyboard, by touch controls or by other means. Communication is also possible from distance, e.g. from a central system in a critical care unit. All the stipulated parts can be integrated into a single apparatus or functionally distributed among different apparatuses. The latter option could mean that e.g. the function serving to control the pneumatic systems is located within the ventilator, whereas e.g. calculation and monitoring functions are physically located in another apparatus such as an external computer.
The control unit receives analogue or digital signals representing flow rate, pressure and C02 and sends signals to the inspiratory and expiratory valves 4 and 12 through means for electronic communication 16. The control unit may apart from components within the ventilator itself comprise components and systems outside the ventilator. The technique of today offers virtually limitless possibilities to embody the invention with respect to technical solutions of electronic components and their communication with each other by wired or wireless means. Monitoring of the ventilation process may be achieved by a system incorporated in the ventilator or by a system outside the ventilator but communicating with the control unit inside the ventilator. The control unit 17 is in a preferred embodiment of the invention equipped with a visual screen for monitoring of flow and pressure signals and for display of other information.
Figure 2
Figure 2 illustrates an alternative preferred embodiment of the invention in which the numbers 1-17 indicate the same structures as in Figure 1. The system used for monitoring according to the present invention is embodied with an apparatus that is separate from the ventilator 1. The monitoring apparatus comprises a computer 20 and transducers for C02 14 flow rate 18 and airway pressure 19, which through wired or wireless means of communication 21 send signals to the computer 20. According to the embodiment illustrated in Figure 2 the invention can be applied to any type of ventilator.
According to a further embodiment of the invention the computer 20 may receive signals for one or more of the parameters flow rate, airway pressure and C02 from transducers integrated in the ventilator thus avoiding duplication of transducer equipment. The computer 20 may also have access to other information from the ventilator 1 such as ventilator setting, respiratory rate and information about timing of partitions of the respiratory cycle through a digital or analogue, wired or wireless communication link. Likewise, the computer 20 may receive information from other sources such as those used for monitoring of circulation like arterial pressure. Figure 3
Figure 3 illustrates a monitoring screen in conjunction with ventilator resetting in a patient with ARDS that was performed at the time 2 minutes. The upper panel A shows Respiratory rate, tidal volume, VT, and Positive End Expiratory Pressure, PEEP. VT is obtained by integration of the flow signal over each breath. PEEP is measured by the transducer 15 or 19. Panel B shows post inspiratory plateau pressure, PPLAT, and the difference between PPLAT and PEEP denoted delta-P. Ideally, delta-P should represent the true difference of the elastic recoil pressure of the respiratory system after and before inspiration. To measure these values exactly, the patient needs to be passive and airway flow rate zero at these moments. Zero flow rate can be achieved with some modern ventilators by closing the valves 4 and 12. Under circumstances this is not achievable or desirable. Then, PPLAT can be determined at minimal inspiratory flow rate towards the end of inspiration. PEEP can be determined at minimal expiratory flow rate towards the end of expiration. These PEEP values can be corrected for flow and resistance dependent pressure gradients in the airways according to principles described by Jonson et al. (Bull. Physiopath. Resp. 1975, v 11 , pp 729-743) Panel C illustrates the volume of C02 eliminated per minute through ventilation, VM|NC02. VMINC02 is calculated from the volume of C02 eliminated during each breath divided by the duration of the breath. VM|NC02 is derived from integration of the product between flow rate and fraction of C02 measured at airway opening. Panel D is a recording of peripheral saturation of oxygen, SP02, measured by conventional means and Panel E shows end tidal C02, ETC02.
In the example.at the initial ventilator setting, monitoring showed that VT, PPLAT and delta-P were higher than conventionally recommended. PaC02 was also high, 62 mmHg. In order to comply with recommendations, at 2 minutes RR was increased from 25 to 33 breaths per minute, VT was reduced from 6.9 to 5.8 ml per kg body weight and PEEP reduced from 12 to 8 cmH20. Immediately after resetting, pressures fell to within recommended values. The immediate increase in VM!NC02 was followed by a slow decline towards initial level. SP02 and ETC02 fell slightly with some delay. Figure 4
Figure 4 Panel A illustrates how different kind of noise can affect the signals, e.g. the one representing VMINC02. Such noise will negatively affect the precision in determination of the change in VMINC02 that occurs after ventilator resetting, in this example at 2 minutes. A slow drift is common in VUINC02 that may reflect changing metabolic rate due to variation in body temperature or varying inflammatory activity in the body as well as other reasons for changing homeostasis. In the example in Figure 4 there is a trend towards increasing VMINC02. A second type of noise is caused by breath by breath variation in volume of C02 eliminated. This variation has several causes such as measurement errors, breath by breath variation in tidal volume and varying pulmonary perfusion at heart arrhythmia.
The slow drift was in the example in Figure 4 mathematically characterized during the 2 minutes before resetting. The heavy straight line in Panel A shows this trend extrapolated to 11 minutes. After setting the trend value at 2 minutes to zero the trend was subtracted from the signal as shown in Panel B. After ventilator resetting, determination of the immediate change in VMINC02, AVMINC02, is an important aspect of the invention. It is therefore important to minimize the influence of breath by breath noise on AVM|NC02. This must be done without applying conventional filtering of the signal over the resetting period.
Before resetting, breath by breath noise in VM)NC02 is reduced by statistical analysis of values before resetting, as illustrated by the solid line during the initial 2 minutes. The value of VMINC02 before resetting is denoted VM|NC02baseline. At resetting, VM|NC02 will immediately increase or decrease to a new value VM|NC02reset. The change will be indirectly proportional to the change in effective alveolar ventilation. During the following period of 15-30 minutes VM|NC02 will slowly return towards the value that represents current metabolic C02 production following an exponential course. To reduce breath by breath noise in VM|NC02 after resetting, VM|NC02 data after resetting are used to analyze this course by statistical means as further described below and in Figure 4 shown by a heavy line representing decline towards baseline. The immediate change of VM|NC02 after resetting, AVM|NC02, is determined from the difference between the VMiNC02reset and VMiNC02baseline as illustrated by interrupted vertical line in Figure 4. Figure 5
Figure 5 shows a numerical display of the same parameters as depicted in figure 3 based on data during 2 minutes before ventilator resetting and 15 s to 2 minutes after resetting. A change is according to a preferred embodiment of the invention accompanied by information about its statistical significance. In this example significant changes (p<0.05) are highlighted in bold characters. SE is standard error of the estimation. Description of preferred embodiments
The system is based upon sensors for airway flow rate, airway pressure and C02 as illustrated in Figure 1 and 2. Flow rate and airway pressure may be measured within the ventilator 5, 13 and 15 in Figure 1 or at the airway opening of the patient 18, 19 in Figure 2. According to preferred embodiments, C02 is measured at the airway opening 14. In an alternative embodiment of the invention, C02 is measured somewhere along the expiratory pneumatic system. Then, the small volume of C02 re-inspired at the start of inspiration from the Y-piece 8 and the inspiratory and expiratory lines 7 and 11 will not be measured. This limitation may be balanced by technical advantages of this alternative embodiment. For all embodiments of the invention, signals for flow rate, airway pressure and C02 should have an adequate frequency response and be adequately in synchrony with each other so that events during breaths representing each signal or combinations of signals can be accurately recorded and monitored. Optional transducers for SP02, arterial pressure and other signals are foreseen to be incorporated in alternative preferred embodiments of the invention.
A computer that may be integrated into the ventilator 17 or be a separate computer 20 samples the signals for C02, airway pressure and flow at an adequate rate. These signals, together with data calculated from the signals and other information may be displayed and stored by the computer in accordance with conventional monitoring systems. Accordingly, volumes are calculated by integration of flow rate over time. Respiratory rate in breaths per minute may be derived from signals controlling the valves of the ventilator 4, 12 or from analysis of pressure and flow signals by the computer 17 or 20.
The objective of the present invention is to monitor parameters providing the most essential information with respect to goal achievement of mechanical ventilation and risks associated with mechanical ventilation and particularly how ventilator resetting affects these parameters. Figure 3 illustrates an example of combinations of such parameters. The combination of parameters may be varied for example with the nature of the disease of the patient and availability of optional transducer signals. The traced parameters are accompanied by numeric information. An example is given in Figure 5. Figure 3 Panel A shows respiratory rate, PEEP and VT, all of which at controlled ventilation are parameters directly related to ventilator setting. Panel B shows the end expiratory plateau pressure, PPLAT, that is the pressure at zero of very low flow rate at the end of an inspiration. PPLAT is the commonly used parameter that indicates the degree of lung distension that when too high will cause lung damage related to hyperdistension. delta-P is the difference between PPLAT and PEEP and is a recommended parameter to estimate risks for VI LI. Panel C describes the elimination of C02 eliminated per minute, VM|NC02. The value is in a preferred embodiment of the invention calculated breath by breath from the integral of the product of flow rate and C02 determined at airway opening with the transducers 5, 13, 14 and 18. Panels D and E show tracings of peripheral oxygen saturation and end tidal C02 concentration.
The primary objective of ventilation, mechanical or spontaneous, is exchange of 02 and C02 so that arterial blood will acquire adequate properties with respect to these gases. For oxygen, focus is often on saturation of haemoglobin that can easily be measured in the periphery, SP02. For C02, the arterial partial pressure of C02, PaC02, is the parameter of primary interest. PaC02 cannot be accurately estimated without analysis of arterial blood samples. Then, apart from blood sampling and costs, a further problem is that the change in PaC02 occurs slowly after a change of alveolar ventilation caused by ventilator resetting. This is due to large C02 stores in body fluids. It may take 30 minutes or more before a new steady state is reached after a change of alveolar ventilation. An alternative to PaC02 is to measure end tidal partial pressure of C02, ETC02. ETC02 is easily obtained from the transducer 14. However, in lung disease ETC02 often differs greatly from PaC02. Furthermore, a change of ETC02 occurs after a similar delay as PaC02 and is influenced by several physiological effects which change with time and with ventilator setting. There is no available method to directly measure or accurately estimate PaC02 at bedside in conjunction with ventilator resetting. However, a change in PaC02 in conjunction with ventilator resetting, APaC02, can according to the invention be estimated within short after resetting as explained below.
VM|NC02 averaged over so long time that body stores of C02 may be regarded as constant represents the rate of C02 production that is proportional to aerobic metabolic rate. A change of VM|NC02 observed after ventilator resetting over such a short time that metabolic rate and body stores of C02 can be regarded as constant reflects a change of efficient alveolar ventilation, which equals total ventilation minus physiological dead space ventilation. Therefore, the determination of the change in VMINC02 occurring immediately after resetting, AVM|NC02, is of particular interest. In stable conditions, such as in controlled ventilation of a sedated patient, AVM|NC02 can often be roughly estimated from observation of the recorded signal Figure 3, Panel C. Very commonly the signal representing VM|NC02 is affected by noise from many sources. Then, an accurate estimation of AVMINC02 cannot be made from visual analysis of the VM|NC02 signal.
Figure 4 with associated text illustrates how the influence of noise on measured AVMINC02 according to a preferred embodiment of the invention is reduced to a level that under most circumstances is adequately low. VM|NC02baseline is calculated from statistical analysis of values during a period preceding ventilator resetting. This analysis not only minimizes breath by breath variation but also allows determination of slow drift. Values after ventilator resetting are corrected for the slow drift characterized before resetting. VMINC02reset is according to preferred embodiments of the invention obtained by statistical analysis of data after resetting. This analysis serves to characterize the slow asymptotic return towards steady state corresponding to the metabolic production of C02. According to a preferred embodiment of the invention an exponential return is anticipated, but similar results may be obtained using alternative mathematical expressions.
Ventilator resetting does not always occur at a specific moment, e.g. when more than one parameter is changed as in the example behind Figure 3. Furthermore, a feature of some ventilators is that ventilator setting is not immediately executed at the moment of resetting but implemented over some breaths. Accordingly, the first breaths following the initiation of resetting must pass before data defining the course of VM|NC02 after resetting is characterized. 5 breaths or 15 s after the last resetting is according to a preferred embodiment of the invention the default for delay of analysis, which by the operator can be prolonged but preferably not to more than about 30 s after last resetting. If longer, the accuracy may decline because of changing C02 stores in body fluids and because data which could lessen the influence of noise are lost. When the course of VM|NC02 after resetting has been characterized, the equation is extrapolated backwards to the time of resetting to obtain VMiNC02reset representing the time of resetting and to calculate AVMINC02 as the difference between VM|NC02reset and VM|NC02baseline. AVM)NC02 denotes the change of C02 elimination at the time of ventilator resetting.
The accuracy of AVM)NC02 is reduced by noise of the VMINC02 signal. The level of noise is according to a preferred embodiment of the invention statistically analyzed. Thereby the influence of noise on the determination of AVM|NC02 can be estimated by applying ordinary statistical methods. The fraction AVMiNC02reset/VMiNC02baseline shows to what extent alveolar ventilation changed in conjunction with ventilator resetting and can be expressed in percent, AVM|NC02%. In the example given in Figure 4, data sets for VM)NC02 2 minutes before and 15 s to 2 minutes after resetting were analyzed. Two minutes may be a suitable default value for those periods. In the presence of heavy noise in the tracing of VMINC02 longer periods may be automatically or manually instituted in order to increase the accuracy of AVMI C02 determination. At controlled ventilation respiratory rate is usually constant. Then, values of eliminated volumes of C02 per breath may be used instead of values for VMINC02 for calculation of the change of C02 elimination in conjunction with ventilator resetting.
PaC02 is proportional to metabolic C02 production and indirectly proportional to efficient alveolar ventilation. As a consequence, the change of PaC02 that will follow resetting after equilibration of body fluid stores of C02 is according to a preferred embodiment of the invention estimated from AVMINC02%. In the example in Figure 4, AVMINC02% was +7% with an estimated range between +6 and +8%. The values for range were estimated using ordinary statistical methods as the 95% confidence interval. This interval serves as default according to a preferred embodiment of the invention. Accordingly, the expected relative change of PaC02 after equilibration was -7%, range -8 to -6%. An alternative to range is to report standard error of the estimated change of PaC02 as illustrated in Figure 5. If information of the PaC02 value before resetting is available in the system, the estimated PaCC½ value after resetting will according to a preferred embodiment of the invention be presented to the operator. If the computer 17 or 20 also has access to present pH value and the acid base status for example expressed as Base excess, the computer can also calculate the expected change in pH by using standard well known equations. The following serves as an example:
Present PaC02 8.3 kPa. Estimated PaC02 after resetting 7.7 kPa (range 7.6-7.8).
Present pH 7.28. Estimated pH after resetting 7.32 It is worth noting that few studies have been published about relationships between observed change of VM|NC02 and change of Pa02 in various patient populations. Secondary feedback reactions in the body may under some circumstances lead to complementary mechanisms which to marginal extent may offset the calculation of PaC02 after ventilator resetting. It is therefore expected that refined algorithms used to predict a change of PaC02 and pH on the basis of AVM|NC02 will be developed for different patient populations.
In Figure 3 and 4 each data point represent a single breath. This is at controlled ventilation a preferred embodiment of the invention. At very irregular breathing VMINC02 and other parameters like tidal volume may vary much between breaths. An alternative embodiment of the invention is to measure parameters over longer periods of time rather than per breath. Determination of volumes of e.g. C02 on the basis of gas flow rate and fraction of C02 are affected by conditions at which flow rate and C02 are measured. Conditions may vary before and after ventilator resetting, particularly with respect to pressure. According to a preferred embodiment of the invention, corrections are made to standardized conditions, for example BTPS (body temperature, atmospheric pressure and saturated with water vapour) or STPD (standard temperature and pressure, saturated). Which standard is chosen does not matter with respect to the present invention. Corrections to a standard is performed according to well known physics utilising information from the airway pressure transducer 15,19. The signal from the C02 transducer may be slightly affected by the oxygen concentration in respired air. When oxygen concentration is changed in association with ventilator resetting, the accuracy of AVMINC02 determination is according to a preferred embodiment of the invention increased by correction of the C02 signal for variation in oxygen concentration. A signal for oxygen concentration in respired air is available in current advanced ventilators.
The analysis of other physiological parameters than VM|NC02 before and after resetting is made by statistical analysis of data sets for each signal sampled before and after resetting. For most parameters, a steady state is to be expected already within a few breaths after resetting. Accordingly, the level of a particular physiological parameter after resetting is determined on the basis of data during a period that according to default setting starts 5 breaths or 15 s after the last resetting and ends 2 minutes later, as for the analysis of VM|NC02. During that period the mean value, range or standard error of the parameter in question is reported. For parameters which attain a steady state after a few breaths, analysis of trends before and after resetting is in contrast to AVM|NC02 not necessary. As ventilator resetting does not occur at an exactly defined moment a change due to ventilator resetting is referred to as a "change in conjunction with ventilator resetting".
End tidal C02, ETC02, has its own particular behaviour after ventilator resetting. As a first approximation it will fall at a rate and to a degree similar to that of PaC02, following an exponential course. However, ETC02 is affected by more physiological factors than PaC02. When for example the respiratory rate is increased and tidal volume decreased, the difference between ETC02 and PaC02 will under most circumstances increase. ETC02 is also affected by the cardiac output and intrapulmonary shunt fraction, which are often affected after ventilator resetting. As variation of ETC02 is complexly affected by both slow and fast phenomena it is in general not useful to predict its upcoming steady state value after ventilator resetting but rather to trace its variation with time as in Figure 3. In spite of the complexity of ETC02 changes it is of value to display this parameter. ETC02 may suddenly fall at an important suppression of pulmonary perfusion that may happen after unsuitable ventilator resetting. At such an event, also VMINC02 falls suddenly. A sudden fall of both ETC02 and VM|NC02 warns against suppressed circulation.
Examples given in Figure 3 and Figure 4 refer to controlled ventilation in a sedated patient. Under such circumstances noise in the signals is in general low. The signal for Respiratory rate and Tidal volume are virtually free from noise. The invention can be applied for other modes of ventilation, for example different types of supported ventilation. Then, the variability of parameters leading to noise in the observations is often much more important. The observation periods over which calculations are performed should then be adapted to the noise level. When the noise becomes so high that values of AVM|NC02% cannot be statistically determined, the prediction of change in PaC02 is according to a preferred embodiment of the invention suppressed.
Apart from a graphical presentation such as that in Figure 3, data before and after ventilator resetting are presented in a numerical format. Figure 5 shows an example based upon the data in Figure 3. According to a preferred embodiment of the invention, the parameters displayed graphically and numerically can be selected in a set up procedure of systems like those in Figure 1 and 2. This option includes parameters not shown in Figure 3. Examples are mean airway pressure and total PEEP. Total PEEP is the pressure in alveoli at the end of expiration that can be measured during a post-expiratory pause or estimated according to principles described by Jonson et al. (Bull. Physiopath. Resp. 1975, v 11 , pp 729-743). According to a preferred embodiment of the invention, signals from haemodynamic monitoring systems and meters for SP02 are transmitted to the computer 17, 20. Such parameters are monitored and analyzed in analogy with parameters from inherent transducers.
Both graphically and numerically presented information are according to a preferred embodiment of the invention stored and may be retrieved for documentation of treatment and for research.

Claims

Claims
A monitoring apparatus for mechanical ventilation comprising transducers for measurement of at least airway flow rate (5, 13, 18) and C02 (14) and a computer (17, 20) that monitors physiological parameters derived from the transducers such as C02 elimination per unit time calculated by integration of the product between flow rate and C02 concentration in expired air, characterized in that the relative change of arterial partial pressure of C02, which after ventilator resetting will occur during establishment of steady state, is estimated on the basis of the relationship between measured value of C02 elimination and the change of C02 elimination measured at the time of ventilator resetting.
A monitoring apparatus according to claim 1 characterized in that the relative change of arterial partial pressure of C02, which after ventilator resetting will occur during establishment of steady state, is estimated on the basis of the quotient between the change of C02 elimination measured at the time of ventilator resetting and a measured value of C02 elimination.
A monitoring apparatus according to claim 1 or 2 characterized in that the value of arterial PC02, which ventilator resetting will lead to after establishment of steady state, is estimated on the basis of the relationship between the change of C02 elimination measured at the time of ventilator resetting and measured value of C02 elimination compiled with a value of arterial PC02.
A monitoring apparatus according to claim 3, characterized in that arterial PC02 combined with other acid/base data measured before resetting are compiled with estimated value of arterial PC02 following the resetting for calculation of arterial pH after establishment of steady state.
A monitoring apparatus according to any of claim 1-4, characterized in that the change in C02 elimination per unit time occurring at ventilator resetting is calculated by statistical analysis of separate data volumes of C02 elimination observed before and after the resetting.
A monitoring apparatus according to claim 4, characterized in that the change in C02 elimination per unit time occurring at ventilator resetting is based upon an equation describing a slow trend of changing C02 elimination per unit time statistically characterised from data measured before ventilator resetting.
A monitoring apparatus according to claim 4, characterized in that the change in C02 elimination per unit time occurring at ventilator resetting is based upon an equation describing a course towards a value that represents steady state, which course is statistically characterised from data measured after ventilator resetting.
A monitoring apparatus according to claim 1 , characterized in a transducer for measurement of airway pressure (15, 19) and in that changes of parameters related to lung mechanics such as postinspiratory plateau pressure and end-expiratory pressure are calculated by statistical analysis of separate data volumes of each parameter before and after the resetting.
A monitoring apparatus according to any of claim 1 to 7, characterized in complementary monitoring equipment transmitting signals to the computer (17, 20), which signals in conjunction with ventilator resetting are monitored on the basis of statistical analysis of separate data volumes of each parameter before and after the resetting, in analogy with parameters from transducers incorporated in the apparatus.
10. A method for monitoring of mechanical ventilation based on measurement of at least airway flow rate (5, 13, 18) and C02 (14) and a computer (17, 20) that monitors physiological parameters derived from the transducers such as C02 elimination per unit time calculated by integration of the product between flow rate and C02 concentration in expired air, characterized in that the relative change of arterial partial pressure of C02, which after ventilator resetting will occur during establishment of steady state, is estimated on the basis of the relationship between measured value of C02 elimination and the change of C02 elimination measured at the time of ventilator resetting.
11. A method for monitoring of mechanical ventilation according to claim 10 characterized in that the relative change of arterial partial pressure of C02, which after ventilator resetting will occur during establishment of steady state, is estimated on the basis of the quotient between the change of C02 elimination measured at the time of ventilator resetting and a measured value of C02 elimination.
12. A method for monitoring of mechanical ventilation according to claim 10 or 11 characterized in that the value of arterial PC02, which ventilator resetting will lead to after establishment of steady state, is estimated on the basis of the relationship between the change of C02 elimination measured at the time of ventilator resetting and measured value of C02 elimination compiled with a value of arterial PC02.
13. A method for monitoring of mechanical ventilation according to claim 12, characterized in that arterial PC02 combined with other acid/base data measured before resetting are compiled with estimated value of arterial PC02 following the resetting for calculation of arterial pH after establishment of steady state.
14. A method for monitoring of mechanical ventilation according to any of claim 10-13, characterized in that the change in CC½ elimination per unit time occurring at ventilator resetting is calculated by statistical analysis of separate data volumes of C02 elimination observed before and after the resetting.
15. A method for monitoring of mechanical ventilation according to claim 14, characterized in that the change in C02 elimination per unit time occurring at ventilator resetting is based upon an equation describing a slow trend of changing C02 elimination per unit time statistically characterised from data measured before ventilator resetting.
16. A method for monitoring of mechanical ventilation according to claim 14, characterized in that the change in C0 elimination per unit time occurring at ventilator resetting is based upon an equation describing a course towards a value that represents steady state, which course is statistically characterised from data measured after ventilator resetting.
17. A method for monitoring of mechanical ventilation according to claim 10, characterized in a transducer for measurement of airway pressure (15, 19) and in that changes of parameters related to lung mechanics such as postinspiratory plateau pressure and end-expiratory pressure are calculated by statistical analysis of separate data volumes of each parameter before and after the resetting.
18. A method for monitoring of mechanical ventilation according to any of claim 10 to 17, characterized in complementary monitoring equipment transmitting signals to the computer (17, 20), which signals in conjunction with ventilator resetting are monitored on the basis of statistical analysis of separate data volumes of each parameter before and after the resetting, in analogy with parameters from transducers incorporated in the apparatus.
PCT/SE2013/000035 2012-03-13 2013-03-11 Apparatus and method for monitoring of mechanical ventilation WO2013137797A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1200155-8 2012-03-13
SE1200155A SE1200155A1 (en) 2012-03-13 2012-03-13 Apparatus for monitoring mechanical ventilation

Publications (1)

Publication Number Publication Date
WO2013137797A1 true WO2013137797A1 (en) 2013-09-19

Family

ID=49161564

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2013/000035 WO2013137797A1 (en) 2012-03-13 2013-03-11 Apparatus and method for monitoring of mechanical ventilation

Country Status (2)

Country Link
SE (1) SE1200155A1 (en)
WO (1) WO2013137797A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069061A (en) * 2016-05-03 2018-12-21 马奎特紧急护理公司 The carbon dioxide of cardiac output or effective pulmonary blood flow volume is tracked during mechanical ventilation
US10668239B2 (en) 2017-11-14 2020-06-02 Covidien Lp Systems and methods for drive pressure spontaneous ventilation
CN111407280A (en) * 2020-03-10 2020-07-14 山东大学 End-tidal CO of noninvasive ventilator2Monitoring device and method
CN113727648A (en) * 2019-04-11 2021-11-30 Obi股份有限公司 Identification and quantification of ventilatory dysfunction leading to incorrect measurement of arterial acid-base status

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931160A (en) * 1995-12-08 1999-08-03 Cardiopulmonary Corporation Ventilator control system and method
US6578575B1 (en) * 1998-04-03 2003-06-17 Siemens Elema Ab Method and apparatus for optimization of mechanical ventilation
US20040003813A1 (en) * 1999-06-30 2004-01-08 Banner Michael J. Medical ventilator and method of controlling same
US20080230065A1 (en) * 2007-03-22 2008-09-25 Erkki Paavo Heinonen Method and system for monitoring patient's breathing action response to changes in a ventilator applied breathing support
US20090107498A1 (en) * 2005-02-10 2009-04-30 Weinmann Geräte für Medizin GmbH & Co. KG Respiratory Equipment and Method for Controlling Respiratory Equipment
US20100037895A1 (en) * 2000-03-07 2010-02-18 Michael Berthon-Jones Determining suitable ventilator settings for patients with alveolar hypoventilation during sleep
US20100275920A1 (en) * 2009-04-30 2010-11-04 General Electric Company System and methods for ventilating a patient
US20110213215A1 (en) * 2010-02-26 2011-09-01 Nellcor Puritan Bennett Llc Spontaneous Breathing Trial Manager
US20110277765A1 (en) * 2007-01-26 2011-11-17 Cs Medical, Inc. System for providing flow-targeted ventilation synchronized to a patient's breathing cycle

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931160A (en) * 1995-12-08 1999-08-03 Cardiopulmonary Corporation Ventilator control system and method
US6578575B1 (en) * 1998-04-03 2003-06-17 Siemens Elema Ab Method and apparatus for optimization of mechanical ventilation
US20040003813A1 (en) * 1999-06-30 2004-01-08 Banner Michael J. Medical ventilator and method of controlling same
US20100037895A1 (en) * 2000-03-07 2010-02-18 Michael Berthon-Jones Determining suitable ventilator settings for patients with alveolar hypoventilation during sleep
US20090107498A1 (en) * 2005-02-10 2009-04-30 Weinmann Geräte für Medizin GmbH & Co. KG Respiratory Equipment and Method for Controlling Respiratory Equipment
US20110277765A1 (en) * 2007-01-26 2011-11-17 Cs Medical, Inc. System for providing flow-targeted ventilation synchronized to a patient's breathing cycle
US20080230065A1 (en) * 2007-03-22 2008-09-25 Erkki Paavo Heinonen Method and system for monitoring patient's breathing action response to changes in a ventilator applied breathing support
US20100275920A1 (en) * 2009-04-30 2010-11-04 General Electric Company System and methods for ventilating a patient
US20110213215A1 (en) * 2010-02-26 2011-09-01 Nellcor Puritan Bennett Llc Spontaneous Breathing Trial Manager

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DEVAQUET ET AL.: "Effects of inspiratory pause on C02 elimination and arterial PC02 in acute lung injury", JOURNAL OF APPLIED PHYSIOLOGY, vol. 105, no. 6, December 2008 (2008-12-01), US, pages 1944 - 1949 *
TASKAR ET AL.: "Dynamics of carbon dioxide elimination following ventilator resetting", CHEST, vol. 108, no. 1, July 1995 (1995-07-01), pages 196 - 202 *
UTTMAN ET AL.: "A prolonged postinspiratory pause enhances C02 elimination by reducing airway dead space", CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, vol. 23, no. 5, September 2003 (2003-09-01), UK, pages 252 - 256 *
UTTMAN ET AL.: "Computer simulation allows goal-oriented mechanical ventilation in acute respiratory distress syndrome", CRITICAL CARE, vol. 11, no. 2, 2007, UK, pages R36, XP021027191, DOI: doi:10.1186/cc5719 *
UTTMAN ET AL.: "Computer-aided ventilator resetting is feasible on the basis of a physiological profile", ACTA ANAESTHESIOLOGICA SCANDINAVICA, vol. 46, no. 3, March 2002 (2002-03-01), DENMARK, pages 289 - 296 *
UTTMAN ET AL.: "Effects of positive end-expiratory pressure increments can be predicted by computer simulation based on a physiological profile in acute respiratory failure", INTENSIVE CARE MEDICINE, vol. 29, no. 2, February 2003 (2003-02-01), DE, pages 226 - 232 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069061A (en) * 2016-05-03 2018-12-21 马奎特紧急护理公司 The carbon dioxide of cardiac output or effective pulmonary blood flow volume is tracked during mechanical ventilation
CN109069061B (en) * 2016-05-03 2021-10-19 马奎特紧急护理公司 Carbon dioxide tracking of cardiac output or effective pulmonary blood flow during mechanical ventilation
US10668239B2 (en) 2017-11-14 2020-06-02 Covidien Lp Systems and methods for drive pressure spontaneous ventilation
US11559643B2 (en) 2017-11-14 2023-01-24 Covidien Lp Systems and methods for ventilation of patients
US11931509B2 (en) 2017-11-14 2024-03-19 Covidien Lp Systems and methods for drive pressure spontaneous ventilation
CN113727648A (en) * 2019-04-11 2021-11-30 Obi股份有限公司 Identification and quantification of ventilatory dysfunction leading to incorrect measurement of arterial acid-base status
CN113727648B (en) * 2019-04-11 2024-02-23 Obi股份有限公司 Identification and quantification of ventilation disorders resulting in incorrect measurement of arterial acid-base status
CN111407280A (en) * 2020-03-10 2020-07-14 山东大学 End-tidal CO of noninvasive ventilator2Monitoring device and method
CN111407280B (en) * 2020-03-10 2022-04-15 山东大学 End-tidal CO of noninvasive ventilator2Monitoring device and method

Also Published As

Publication number Publication date
SE1200155A1 (en) 2013-09-14

Similar Documents

Publication Publication Date Title
US11033700B2 (en) Leak determination in a breathing assistance system
US6709405B2 (en) Breathing apparatus and method for operation thereof for examining pulmonary mechanics of a respiratory system
AU2011218803B2 (en) A method for estimating at least one parameter at a patient circuit wye in a medical ventilator providing ventilation to a patient
US11413415B2 (en) Estimating lung compliance and lung resistance using a pressure controlled breath to allow all respiratory muscle recoil generated pressure to vanish
US11850358B2 (en) Smart control system and method based on machine learning for modulating end-tidal concentration levels by means of adjustments to the volume and concentration of an incoming respiratory gas flow in real time
JP2019500927A (en) Method, apparatus and system for automatically controlling inhaled oxygen distribution
JP2015506189A (en) Method and apparatus for monitoring and controlling pressure assist devices
US20150231351A1 (en) System for optimal mechanical ventilation
JP2018515292A (en) Method, system and software for protective ventilation
US11738161B2 (en) System and method for adaptive scheduling of pause maneuvers used for estimation of compliance and/or resistance during mechanical ventilation
WO2013137797A1 (en) Apparatus and method for monitoring of mechanical ventilation
JP6912388B2 (en) Non-invasive method of monitoring patient respiratory status via sequential parameter estimation
US20070089744A1 (en) Method for determining a cardiac data characteristic
US20230419527A1 (en) Accurate diaphragm thickness and function evaluation using ultrasound and mechanical ventilator signals
CN103285479B (en) Device for monitoring airway collapse characteristic parameters of breathing machine
Devlieger et al. The flow-pressure plot: a new look on the patient-ventilator interaction in neonatal care
WO2023212486A2 (en) Modular respiratory sensor integration block system
DELCAMBRE et al. DATA MANAGEMENT AND REAL TIME RESPIRATORY SIGNALS PROCESSING IN ANESTHESIA
UA115261U (en) DEVICES FOR DETERMINING HUMAN ORGANISM RESISTANCE TO HYPOXIA

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13761797

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13761797

Country of ref document: EP

Kind code of ref document: A1